Metraipolis › archive › dc_7aff3e5c7802

Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection — Europe PMC PMID:41206830

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41206830
DOI
10.1007/s00125-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-08T17:14:47.323Z
SHA-256 of the archived text
78b7adabde2db20db1ebe3d9a41b72158facda3885a50038ddd8d7e3e3720b64
Stable URL of this page
https://metraipolis.com/documento/dc_7aff3e5c7802

How to cite

Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection — Europe PMC PMID:41206830 — Europe PMC (en), https://europepmc.org/article/MED/41206830 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7aff3e5c7802 (Metraipolis archive dc_7aff3e5c7802, sha256 78b7adabde2db20db1ebe3d9a41b72158facda3885a50038ddd8d7e3e3720b64)
BibTeX
@misc{dc7aff3e5c7802,
  title = {Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection — Europe PMC PMID:41206830},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41206830},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7aff3e5c7802; sha256 78b7adabde2db20db1ebe3d9a41b72158facda3885a50038ddd8d7e3e3720b64},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41206830. Agents can read the archived copy with the MCP tool read_document.